Intravascular Lymphoma Presenting as Acute Abdomen With Intestinal PerforationSeptember 12, 2018Lymphoma & Plasma Cell Disorders
RESONATE-2 update: First-line ibrutinib has sustained efficacy in older CLL patientsSeptember 6, 2018Lymphoma & Plasma Cell Disorders
Fracture risk linked to mortality in women with myelomaAugust 29, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Treatment simulation could help personalize myeloma therapyJuly 31, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Promising phase 3 results for ixazomib in multiple myelomaJuly 13, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
FDA grants regular approval to venetoclax for CLL/SLLJune 8, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Ruxolitinib overcame lenalidomide resistance in myelomaJune 3, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
CAR T therapy to enter early testing in multiple myelomaMay 30, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Sorafenib Improves Survival for Patients With Rare SarcomasMay 10, 2018OncologyLymphoma & Plasma Cell Disorders
FDA places partial hold on trials after secondary lymphomaApril 25, 2018Lymphoma & Plasma Cell Disorders
In myeloma, third ASCT is a viable optionMarch 14, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
